Bank of New York Mellon’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.09M Buy
612,470
+15,951
+3% +$80.4K ﹤0.01% 2523
2025
Q1
$3.87M Sell
596,519
-7,548
-1% -$48.9K ﹤0.01% 2350
2024
Q4
$4.43M Sell
604,067
-38,216
-6% -$281K ﹤0.01% 2347
2024
Q3
$4.81M Sell
642,283
-171,005
-21% -$1.28M ﹤0.01% 2305
2024
Q2
$7.24M Buy
813,288
+6,359
+0.8% +$56.6K ﹤0.01% 2135
2024
Q1
$8.17M Buy
806,929
+86,031
+12% +$871K ﹤0.01% 2061
2023
Q4
$7.25M Sell
720,898
-140,586
-16% -$1.41M ﹤0.01% 2175
2023
Q3
$8.07M Buy
861,484
+24,492
+3% +$229K ﹤0.01% 2060
2023
Q2
$20.5M Buy
836,992
+13,824
+2% +$339K ﹤0.01% 1542
2023
Q1
$19.2M Sell
823,168
-13,232
-2% -$308K ﹤0.01% 1567
2022
Q4
$21.2M Buy
836,400
+106,313
+15% +$2.69M ﹤0.01% 1508
2022
Q3
$14.1M Buy
730,087
+28,094
+4% +$542K ﹤0.01% 1693
2022
Q2
$17.9M Buy
701,993
+427,490
+156% +$10.9M ﹤0.01% 1596
2022
Q1
$7.06M Sell
274,503
-4,381
-2% -$113K ﹤0.01% 2257
2021
Q4
$11.7M Buy
278,884
+17,132
+7% +$717K ﹤0.01% 2022
2021
Q3
$11.4M Buy
261,752
+21,861
+9% +$951K ﹤0.01% 2046
2021
Q2
$11.3M Buy
239,891
+68,585
+40% +$3.24M ﹤0.01% 2061
2021
Q1
$8.78M Sell
171,306
-9,919
-5% -$508K ﹤0.01% 2160
2020
Q4
$4.85M Buy
181,225
+16,219
+10% +$434K ﹤0.01% 2368
2020
Q3
$5.66M Buy
165,006
+41,176
+33% +$1.41M ﹤0.01% 2151
2020
Q2
$5.07M Buy
123,830
+104,213
+531% +$4.27M ﹤0.01% 2200
2020
Q1
$672K Buy
19,617
+6,674
+52% +$229K ﹤0.01% 3223
2019
Q4
$163K Buy
+12,943
New +$163K ﹤0.01% 3953